Jean-David Fumet

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 416 citations · Full text

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · British Journal of Cancer · 2019 · 206 citations · Full text

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Emeric Limagne, Lisa Nuttin, Marion Thibaudin et al. · Cancer Cell · 2022 · 199 citations

Cancer Immunosurveillance, Oncology, Medicine +11

Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients

Emeric Limagne, Corentin Richard, Marion Thibaudin et al. · OncoImmunology · 2019 · 198 citations · Full text

Secondary Resistances, Pd-1 Blockade, Immunology +16

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Jean-David Fumet, Corentin Richard, Fanny Ledys et al. · British Journal of Cancer · 2018 · 169 citations · Full text